Bay K8644
Names | |
---|---|
IUPAC name
Methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate | |
Identifiers | |
71145-03-4 | |
3D model (Jmol) | Interactive image |
ChEBI | CHEBI:34555 |
ChEMBL | ChEMBL513599 |
ChemSpider | 2213 |
ECHA InfoCard | 100.163.930 |
2511 | |
PubChem | 2303 |
| |
| |
Properties | |
C16H15F3N2O4 | |
Molar mass | 356.30 g·mol−1 |
Insoluble | |
Solubility in other solvents | DMSO: 184 mg/mL; methanol and ethanol: 63 mg/mL |
Hazards | |
EU classification (DSD) |
Xi |
R-phrases | R36/38 |
S-phrases | S26 S36 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Bay K8644 is a chemical compound that functions as a calcium channel agonist. Bay K8644 is used primarily as a biochemical research tool for this effect.[2] It is a structural analog of nifedipine with positive inotropic activity, and as an aromatic it is highly lipid soluble.
Mechanism of Action
Bay K8644 targets Voltage-sensitive dihydropyridine (DHP) Calcium Channels (L-Type). It is the first positive inotropic agent shown to act specifically and directly on calcium channels.[3]
References
- ↑ (±)-Bay K8644 at Sigma-Aldrich
- ↑ Bay K8644 at PubChem
- ↑ Thomas, G; Chung, M; Cohen, CJ (January 1985). "A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent.". Circ Res. PMID 2578336.
This article is issued from Wikipedia - version of the 11/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.